@inproceedings{inproceedings, title = {{Adjusting for treatment crossover in the BREAK-3 metastatic melanoma trial for dabrafenib: Preliminary analysis}}, url = {{}}, year = {{2013}}, month = {{5}}, author = {{Latimer N and Abrams KR and Amonkar M and Stapelkamp C and Swann RS}}, volume = {{31}}, journal = {{JOURNAL OF CLINICAL ONCOLOGY}}, issue = {{15}}, note = {{Accessed on 2025/06/26}}}